McKesson | MCK - Ebitda

Stock Price
828.11
Daily Change
-7.99 -0.96%
Monthly
-5.87%
Yearly
19.15%
Q2 Forecast
810.39

McKesson reported $1.68B in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Acadia Healthcare USD 99.85M 73.17M Dec/2025
Align Technology USD 183.84M 19.77M Sep/2025
Cardinal Health USD 981M 5M Dec/2025
Centene USD -903M 1.02B Dec/2025
Charles River Laboratories USD 258.06M 24.83M Dec/2025
Cigna USD 2.86B 56M Mar/2025
Community Health Systems USD 395M 19M Dec/2025
Computer Programs Systems USD 19.2M 10.52M Dec/2025
CVS Health USD 3.74B 349M Dec/2025
DaVita Healthcare Partners USD 772.7M 89.45M Dec/2025
Dentsply International USD 135M 32M Dec/2025
Elevance Health USD 4.21B 2.02B Mar/2026
Encompass Health USD 335.6M 35.5M Dec/2025
HCA USD 3.8B 312M Mar/2026
Henry Schein USD 291M 4M Dec/2025
Humana USD -290M 1.11B Dec/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
J&J USD 7.19B 2.32B Dec/2025
Laboratory Of America USD 588.1M 24.1M Dec/2025
McKesson USD 1.68B 418M Sep/2025
Molina Healthcare USD 267M 385M Mar/2026
Owens Minor USD 90.02M 2.15M Dec/2025
Quest Diagnostics USD 557M 20M Mar/2026
Stryker USD 1.67B 206M Sep/2025
Tenet Healthcare USD 1.18B 84M Dec/2025
UnitedHealth USD 9.99B 8.5B Mar/2026
Universal Health Services USD 678.67M 8.07M Dec/2025
Veradigm USD 38.81M 29.61M Sep/2022